Table 3.

Expression on MCs of FcεRI α chain

TreatmentCB-derivednPB-derivednP
MFI ratio (surface) (—) 1.04 ± 0.02 1.71 ±  0.12 <.05 
 IgE 1.95 ± 0.61 10.37 ±  1.47 <.005 
 IgE + IL-4 3.64 ± 1.21 16.82 ±  2.16 <.005 
MFI ratio (permeabilized) (—) 5.14 ± 0.43 15.77 ±  2.39 <.05 
 IgE 6.63 ± 1.68 32.59 ±  7.70 <.005 
 IgE + IL-4 10.60 ± 2.41 46.79 ± 11.71 <.01 
TreatmentCB-derivednPB-derivednP
MFI ratio (surface) (—) 1.04 ± 0.02 1.71 ±  0.12 <.05 
 IgE 1.95 ± 0.61 10.37 ±  1.47 <.005 
 IgE + IL-4 3.64 ± 1.21 16.82 ±  2.16 <.005 
MFI ratio (permeabilized) (—) 5.14 ± 0.43 15.77 ±  2.39 <.05 
 IgE 6.63 ± 1.68 32.59 ±  7.70 <.005 
 IgE + IL-4 10.60 ± 2.41 46.79 ± 11.71 <.01 

CB-derived MCs or PB-derived MCs were pretreated with 1 μg/mL IgE or IgE + 10 ng/mL IL-4 for 48 hours. After washing, cell surface (surface) or cell surface and intracytoplasmic (permeabilized) FcεRIα were stained. Each value represents an average ± SEM of the MFI ratio (specific value/spontaneous value). Experiment number (n) was 5 to 7, as indicated.

Close Modal

or Create an Account

Close Modal
Close Modal